Puma Biotechnology, Inc. (PBYI)

Puma Biotechnology Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	54.66	69.22	84.59	76.2	63.13	85.29
Short-Term Investments	41.36	31.75	11.35	4.87	18.98	8.1
Cash & Short-Term Investments	96.02	100.97	95.94	81.07	82.11	93.39
Cash Growth	-0.83%	5.24%	18.34%	-1.26%	-12.08%	-16.35%
Accounts Receivable	25.91	32.01	47.84	40.35	32.53	25.54
Inventory	8.59	8.72	7.08	4.53	7.11	3.45
Other Current Assets	6.05	5.96	5.33	8.33	18.28	23.75
Total Current Assets	136.58	147.66	156.19	134.28	140.02	146.14
Net Property, Plant & Equipment	3.22	5.09	8.65	12.51	15.77	18.89
Other Intangible Assets	46.26	51.13	60.87	70.61	66.13	74.14
Other Long-Term Assets	8.86	9.45	4.83	4.66	4.67	5.06
Total Assets	194.92	213.33	230.53	222.06	226.59	244.22
Accounts Payable	5.42	5.51	6.89	6.44	11.17	12.08
Accrued Expenses	31.8	36.9	52.72	65.53	92.58	82.32
Current Portion of Long-Term Debt	34	45.33	34	-	-	14.29
Current Portion of Leases	4.36	5.54	4.8	4.14	3.57	3.09
Other Current Liabilities	3.52	2.84	0.98	1.37	2.26	2.48
Total Current Liabilities	79.1	96.11	99.38	77.48	109.59	114.26
Long-Term Debt	10.87	21.72	65.66	98.31	97.09	84.03
Long-Term Leases	0.23	1.49	7.03	11.83	15.98	19.55
Other Long-Term Liabilities	-	1.88	5.01	12.83	6.38	32.34
Total Long-Term Liabilities	11.1	25.1	77.7	122.97	119.45	135.92
Total Liabilities	90.2	121.21	177.09	200.45	229.03	250.17
Common Stock	0.01	0.01	0.01	0.01	0	0
Additional Paid-in Capital	1,411	1,407	1,399	1,388	1,364	1,332
Accumulated Other Comprehensive Income	-0.01	0.01	-0	-	-0	-
Retained Earnings	-1,306	-1,315	-1,345	-1,367	-1,367	-1,338
Shareholders' Equity	104.72	92.13	53.44	21.61	-2.45	-5.95
Total Liabilities & Equity	194.92	213.33	230.53	222.06	226.59	244.22
Total Debt	49.46	74.08	111.49	114.28	116.64	120.95
Net Cash (Debt)	46.56	26.88	-15.55	-33.21	-34.54	-27.57
Net Cash Growth	73.21%	-	-	-	-	-
Net Cash Per Share	0.94	0.55	-0.33	-0.74	-0.85	-0.70
Book Value	104.72	92.13	53.44	21.61	-2.45	-5.95
Book Value Per Share	2.11	1.88	1.12	0.48	-0.06	-0.15
Tangible Book Value	58.46	40.99	-7.43	-49	-68.57	-80.09
Tangible Book Value Per Share	1.18	0.83	-0.16	-1.09	-1.69	-2.02

Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q